Is State Street SPDR S&P Health Care Services ETF (XHS) a Strong ETF Right Now?

The State Street SPDR S&P Health Care Services ETF (XHS) was launched on 09/28/2011, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Zacks Investment Research • Sep 17, 2026

Should You Invest in the State Street SPDR S&P Health Care Services ETF (XHS)?

If you're interested in broad exposure to the Healthcare - Services segment of the equity market, look no further than the State Street SPDR S&P Health Care Services ETF (XHS), a passively managed exchange traded fund launched on September 28, 2011.

Zacks Investment Research • Sep 14, 2026

Healthcare Rules State Street's Top 5 ETFs in Past Month

With well over 170 ETFs on the market covering diverse investment strategies, State Street offers a prime window into which funds — and market trends — are leading the pack in the near term. Key Takeaways: Across State Street's 170+ ETFs, the top five performers this past month are all tied to the healthcare industry.

ETF Trends • Jul 17, 2026

Best ETF Areas of June

Biotech, China, insurance and healthcare ETFs led June gains as strong earnings, AI optimism and easing geopolitical fears lifted markets.

Zacks Investment Research • Jul 6, 2026

Health Care Services ETF (XHS) Touches a New 52-Week High

XHS hits a new 52-week high as healthcare-services stocks gain from steady earnings and defensive investor positioning.

Zacks Investment Research • May 29, 2026

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Seeking Alpha • May 2, 2026

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

Seeking Alpha • Apr 12, 2026

Can Forgotten Biotech Break Out?

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

Seeking Alpha • Apr 11, 2026

Best-Performing ETFs of Last Week: Healthcare Rules

Healthcare and biotech led last week's winners, with EPHE, BBC, HELX, XHS and SURI topping ETF gains as markets slid on AI worries and Fed uncertainty.

Zacks Investment Research • Nov 24, 2025

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025